Sigma-Tau Recalls Oncaspar Injection Due to Sterility Concerns
Sigma-Tau Pharmaceuticals is voluntarily recalling five lots of Oncaspar Injection because a crack under the crimp seal caused a leak, compromising sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. According to the rubric, FDA Class II recalls with potential for significant injury (such as loss of sterility in an injectable drug) are classified as Severe.
Plain-English summary
Sigma-Tau Pharmaceuticals, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection (PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial). The recall is being conducted because a crack under the crimp seal caused a leak in the vials.
The affected product is identified by the following lot numbers and expiration dates: Lot# 3012A, 3013A, 30138 (Exp. 11/13) and Lot# 3014A, 3014A CLIN (Exp. 12/13). The recall covers 7,479 vials that were distributed nationwide.
The FDA has classified this recall as Class II. The primary hazard is the lack of assurance of sterility due to the physical defect in the packaging. Patients and healthcare providers should stop using the affected lots and contact their healthcare provider or the manufacturer for further instructions.
The recalled product
- Product
- PEGASPARGASE ONCASPAR Injection, 3750 International Units Per 5mL vial, Rx ONLY, sigma-tau PHARMACEUTICALS INC, 9841 Washingtonian Blvd, Gaithersburg, MD 20878 NDC 54482-301-01
- Manufacturer
- Sigma-Tau Pharmaceuticals, Inc.
- Category
- Drug — Injectable
- Affected units
- 7,479
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot# 3012A
- 3013A
- 30138
- Exp. 11/13 Lot# 3014A
- 3014A CLIN
- Exp. 12/13
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29